Expression levels of genes important for MK development
Description . | GenBank accession no. . | Normal MK signal . | ET MK signal . | SLR . | Quantitative RT-PCR SLR . |
---|---|---|---|---|---|
Selected proteins | |||||
Glycoprotein Ib (platelet), alpha polypeptide | NM_000173.1 | 3028.7, P | 3630.25, P | 0.28, NC | 1.5 |
Glycoprotein VI (platelet) | AB043821.1 | 314.9, P | 381.1, P | 0.22, NC | NA |
Glycoprotein IX (platelet) | NM_000174.1 | 983.3, P | 619.7, P | -0.54, NC | NA |
Integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41B) | NM_000419.2 | 3829.7, P | 4136.4, P | 0.33, NC | 1.1 |
Integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | AI189839 | 469.9, P | 288.8, P | -0.38, NC | 1.5 |
CD9 antigen (p24) | NM_001769.1 | 2652.9, P | 2360, P | -0.17, NC | NA |
Inhibitor | |||||
Transforming growth factor, beta 1 (Camurati-Engelmann disease) | BC000125.1 | 2953.9, P | 3440.9, P | 0.2, NC | 1.1 |
Growth factors | |||||
Interleukin 1, beta | M15330 | 208.4, P | 154.6, P | -0.3, NC | NA |
Interleukin 1, beta | NM_000576.1 | 329.4, P | 285, P | -0.27, NC | NA |
Interleukin 6 (interferon, beta 2) | NM_000600.1 | —, A | 16.9, P | -0.11, NC | NA |
Interleukin 11 | NM_000641.1 | —, A | —, A | —, NC | NA |
Platelet-derived growth factor alpha polypeptide | NM_002607.1 | 223.9, P | 267.5, P | 0.4, I | 1.5 |
Platelet-derived growth factor beta polypeptide | AK022920.1 | 21.7, P | 23.7, P | -0.26, NC | NA |
Platelet-derived growth factor C | NM_016205.1 | 651.6, P | 708.8, P | 0.21, NC | 1.4 |
Vascular endothelial growth factor | AF022375.1 | 568.6, P | 467.2, P | -0.32, NC | NA |
Growth factors receptors | |||||
Interleukin 1 receptor | NM_000877.1 | —, A | —, A | —, NC | NA |
Interleukin 3 receptor | NM_002183.1 | —, A | —, A | —, NC | NA |
Interleukin 6 receptor | NM_000565.1 | 67.1, P | 43.2, P | -0.69, NC | 0.1 |
Interleukin 11 receptor | NM_004512.1 | —, A | —, A | —, NC | NA |
Myeloproliferative leukemia virus oncogene | NM_005373.1 | 474.8, P | 554.7, P | -0.01, NC | NA |
V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | NM_000222.1 | 223.7, P | 165.1, P | -0.9, D | NA |
Chemokine (C-X-C motif) receptor 4 | AJ224869 | 1505.5, P | 957.7, P | -0.48, NC | 1.0 |
Thromboxane A2 receptor | D38081 | 653.6, P | 690.8, P | 0.38, NC | 1.5 |
Cell cycle regulators | |||||
Cyclin B1 | BE407516 | 128.6, P | 159.5, P | 0.15, NC | NA |
Cyclin D3 | NM_001760.1 | 3247.9, P | 3241.9, P | 0, NC | 0.7 |
Cyclin E1 | AI671049 | 31.1, P | —, A | -0.52, NC | NA |
Cyclin E2 | NM_004702.1 | 44.7, P | 34, P | -0.24, NC | NA |
Cell division cycle 2, G1 to S and G2 to M | AL524035 | 287, P | 136.8, P | -0.65, D | NA |
Cyclin-dependent kinase 2 | M68520.1 | 240.9, P | 172.4, P | -0.12, NC | NA |
Cyclin-dependent kinase inhibitor 1B (p27, Kip1) | BC001971.1 | 309, P | 232.5, P | -0.44, NC | NA |
RAS p21 protein activator (GTPase activating protein) 1 | M23612.1 | 339.9, P | 271.2, P | -0.45, D | NA |
Cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4 | NM_000077.1 | —, A | —, A | —, NC | NA |
RAS guanyl releasing protein 2 (calcium and DAG-regulated) | NM_005825.1 | 637.9, P | 868.2, P | 0.36, NC | 1.6 |
Apoptosis regulators | |||||
BCL2-antagonist of cell death | U66879 | 37.6, P | 23, A | -0.02, NC | NA |
BCL2-antagonist/killer 1 | NM_001188.1 | 66.2, P | 82.1, P | -0.13, NC | NA |
BCL2-like 2 | D87461.1 | 112, P | 174.2, P | 0.42, NC | NA |
B-cell CLL/lymphoma 2 | NM_000633.1 | 16.6, P | 21.1, P | 0.3, NC | NA |
Caspase-3, apoptosis-related cysteine protease | NM_004346.1 | 115.3, P | 155.4, P | 0.53, I | 1.7 |
Caspase-9, apoptosis-related cysteine protease | U60521.1 | 171.8, P | 196.5, P | 0.07, NC | 0.9 |
Myeloid cell leukemia sequence 1 (BCL2-related) | NM_021960.1 | 874.6, P | 1078.7, P | 0.3, NC | 1.5 |
Transcriptional regulators | |||||
Friend leukemia virus integration 1 | NM_002017.2 | 538.1, P | 322, P | -0.52, D | NA |
GATA binding protein 1 (globin transcription factor 1) | M30601.1 | 606, P | 677.6, P | 0.18, NC | NA |
GATA binding protein 2 | NM_002050.1 | 67.7, P | 83.2, P | -0.09, NC | NA |
Jumonji homolog (mouse) | BG029530 | 1139.2, P | 911.1, P | 0.19, NC | NA |
Jun D proto-oncogene | NM_005354.2 | 2139.5, P | 2371.8, P | 0.24, NC | 1.1 |
V-jun sarcoma virus 17 oncogene homolog (avian) | BE327172 | 8.45, P | 27.6, P | 1.26, NC | NA |
Kruppel-like factor 1 (erythroid) | U65404.1 | 96, P | 83, P | 0.05, NC | NA |
V-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian) | NM_002359.1 | 299.5, P | 286.9, P | 0.39, NC | NA |
V-myb myeloblastosis viral oncogene homolog (avian) | NM_005375.1 | 85.2, P | 96.35, P | -0.16, NC | NA |
V-myc myelocytomatosis viral oncogene homolog (avian) | NM_002467.1 | 317.6, P | 353.6, P | 0.42, NC | NA |
V-fos FBJ murine osteosarcoma viral oncogene homolog | BC004490.1 | —, A | —, A | —, NC | 0.0 |
Nuclear factor (erythroid-derived 2), 45 kDa | L13974.1 | 1386.8, P | 1419.3, P | 0.03, NC | 1.1 |
T-cell acute lymphocytic leukemia 1 | NM_003189.1 | 1873.2, P | 1763.8, P | 0.03, NC | 1.1 |
Ecotropic viral integration site 1 | S82592.1 | —, A | —, A | —, NC | NA |
Core-binding factor, runt domain, alpha subunit 2; translocated to 3 | NM_005187.2 | 234.7, P | 377.1, P | 0.57, I | 1.6 |
Core-binding factor, runt domain, alpha subunit 2; translocated to 2 | NM_005093.1 | 69.1, P | 80.3, P | 0.33, NC | NA |
Chemokines | |||||
GRO1 oncogene (melanoma growth stimulating activity, alpha) | NM_001511.1 | 20.65, P | 157.8, P | 2.33, I | 3.2 |
Stromal cell-derived factor 1 | U19495.1 | 30.8, P | 62.9, P | 0.5, I | 2.6 |
Interleukin 8 | NM_000584.1 | 435.8, P | 1601.3, P | 1.87, I | 3.9 |
Proplatelet basic protein | R64130 | 4476.1, P | 4161.7, P | 0.06, NC | 0.7 |
Small inducible cytokine A5 (Rantes) | M21121 | 302.1, P | 524.3, P | 0.44, NC | NA |
Platelet factor 4 | NM_002619.1 | 6642.2, P | 7639.8, P | 0.12, NC | 0.7 |
Signal transducers | |||||
Signal transducer and activator of transcription | M97935 | 148.8, P | 132, P | 0.05, NC | NA |
Signal transducer and activator of transcription 3 | BC000627.1 | 503.3, P | 375.2, P | -0.46, NC | NA |
Signal transducer and activator of transcription 5A | NM_003152.1 | 229.9, P | 248.5, P | 0.11, NC | NA |
Mitogen-activated protein kinase 14 | NM_001315.1 | 681, P | 535.2, P | -0.57, D | 0.9 |
Janus kinase 2 (a protein tyrosine kinase) | NM_004972.2 | 45.5, P | 34.6, P | -0.08, NC | NA |
Phosphoinositide-3-kinase, class 2, beta polypeptide | NM_002646.1 | —, A | —, A | —, NC | NA |
Description . | GenBank accession no. . | Normal MK signal . | ET MK signal . | SLR . | Quantitative RT-PCR SLR . |
---|---|---|---|---|---|
Selected proteins | |||||
Glycoprotein Ib (platelet), alpha polypeptide | NM_000173.1 | 3028.7, P | 3630.25, P | 0.28, NC | 1.5 |
Glycoprotein VI (platelet) | AB043821.1 | 314.9, P | 381.1, P | 0.22, NC | NA |
Glycoprotein IX (platelet) | NM_000174.1 | 983.3, P | 619.7, P | -0.54, NC | NA |
Integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41B) | NM_000419.2 | 3829.7, P | 4136.4, P | 0.33, NC | 1.1 |
Integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | AI189839 | 469.9, P | 288.8, P | -0.38, NC | 1.5 |
CD9 antigen (p24) | NM_001769.1 | 2652.9, P | 2360, P | -0.17, NC | NA |
Inhibitor | |||||
Transforming growth factor, beta 1 (Camurati-Engelmann disease) | BC000125.1 | 2953.9, P | 3440.9, P | 0.2, NC | 1.1 |
Growth factors | |||||
Interleukin 1, beta | M15330 | 208.4, P | 154.6, P | -0.3, NC | NA |
Interleukin 1, beta | NM_000576.1 | 329.4, P | 285, P | -0.27, NC | NA |
Interleukin 6 (interferon, beta 2) | NM_000600.1 | —, A | 16.9, P | -0.11, NC | NA |
Interleukin 11 | NM_000641.1 | —, A | —, A | —, NC | NA |
Platelet-derived growth factor alpha polypeptide | NM_002607.1 | 223.9, P | 267.5, P | 0.4, I | 1.5 |
Platelet-derived growth factor beta polypeptide | AK022920.1 | 21.7, P | 23.7, P | -0.26, NC | NA |
Platelet-derived growth factor C | NM_016205.1 | 651.6, P | 708.8, P | 0.21, NC | 1.4 |
Vascular endothelial growth factor | AF022375.1 | 568.6, P | 467.2, P | -0.32, NC | NA |
Growth factors receptors | |||||
Interleukin 1 receptor | NM_000877.1 | —, A | —, A | —, NC | NA |
Interleukin 3 receptor | NM_002183.1 | —, A | —, A | —, NC | NA |
Interleukin 6 receptor | NM_000565.1 | 67.1, P | 43.2, P | -0.69, NC | 0.1 |
Interleukin 11 receptor | NM_004512.1 | —, A | —, A | —, NC | NA |
Myeloproliferative leukemia virus oncogene | NM_005373.1 | 474.8, P | 554.7, P | -0.01, NC | NA |
V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | NM_000222.1 | 223.7, P | 165.1, P | -0.9, D | NA |
Chemokine (C-X-C motif) receptor 4 | AJ224869 | 1505.5, P | 957.7, P | -0.48, NC | 1.0 |
Thromboxane A2 receptor | D38081 | 653.6, P | 690.8, P | 0.38, NC | 1.5 |
Cell cycle regulators | |||||
Cyclin B1 | BE407516 | 128.6, P | 159.5, P | 0.15, NC | NA |
Cyclin D3 | NM_001760.1 | 3247.9, P | 3241.9, P | 0, NC | 0.7 |
Cyclin E1 | AI671049 | 31.1, P | —, A | -0.52, NC | NA |
Cyclin E2 | NM_004702.1 | 44.7, P | 34, P | -0.24, NC | NA |
Cell division cycle 2, G1 to S and G2 to M | AL524035 | 287, P | 136.8, P | -0.65, D | NA |
Cyclin-dependent kinase 2 | M68520.1 | 240.9, P | 172.4, P | -0.12, NC | NA |
Cyclin-dependent kinase inhibitor 1B (p27, Kip1) | BC001971.1 | 309, P | 232.5, P | -0.44, NC | NA |
RAS p21 protein activator (GTPase activating protein) 1 | M23612.1 | 339.9, P | 271.2, P | -0.45, D | NA |
Cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4 | NM_000077.1 | —, A | —, A | —, NC | NA |
RAS guanyl releasing protein 2 (calcium and DAG-regulated) | NM_005825.1 | 637.9, P | 868.2, P | 0.36, NC | 1.6 |
Apoptosis regulators | |||||
BCL2-antagonist of cell death | U66879 | 37.6, P | 23, A | -0.02, NC | NA |
BCL2-antagonist/killer 1 | NM_001188.1 | 66.2, P | 82.1, P | -0.13, NC | NA |
BCL2-like 2 | D87461.1 | 112, P | 174.2, P | 0.42, NC | NA |
B-cell CLL/lymphoma 2 | NM_000633.1 | 16.6, P | 21.1, P | 0.3, NC | NA |
Caspase-3, apoptosis-related cysteine protease | NM_004346.1 | 115.3, P | 155.4, P | 0.53, I | 1.7 |
Caspase-9, apoptosis-related cysteine protease | U60521.1 | 171.8, P | 196.5, P | 0.07, NC | 0.9 |
Myeloid cell leukemia sequence 1 (BCL2-related) | NM_021960.1 | 874.6, P | 1078.7, P | 0.3, NC | 1.5 |
Transcriptional regulators | |||||
Friend leukemia virus integration 1 | NM_002017.2 | 538.1, P | 322, P | -0.52, D | NA |
GATA binding protein 1 (globin transcription factor 1) | M30601.1 | 606, P | 677.6, P | 0.18, NC | NA |
GATA binding protein 2 | NM_002050.1 | 67.7, P | 83.2, P | -0.09, NC | NA |
Jumonji homolog (mouse) | BG029530 | 1139.2, P | 911.1, P | 0.19, NC | NA |
Jun D proto-oncogene | NM_005354.2 | 2139.5, P | 2371.8, P | 0.24, NC | 1.1 |
V-jun sarcoma virus 17 oncogene homolog (avian) | BE327172 | 8.45, P | 27.6, P | 1.26, NC | NA |
Kruppel-like factor 1 (erythroid) | U65404.1 | 96, P | 83, P | 0.05, NC | NA |
V-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian) | NM_002359.1 | 299.5, P | 286.9, P | 0.39, NC | NA |
V-myb myeloblastosis viral oncogene homolog (avian) | NM_005375.1 | 85.2, P | 96.35, P | -0.16, NC | NA |
V-myc myelocytomatosis viral oncogene homolog (avian) | NM_002467.1 | 317.6, P | 353.6, P | 0.42, NC | NA |
V-fos FBJ murine osteosarcoma viral oncogene homolog | BC004490.1 | —, A | —, A | —, NC | 0.0 |
Nuclear factor (erythroid-derived 2), 45 kDa | L13974.1 | 1386.8, P | 1419.3, P | 0.03, NC | 1.1 |
T-cell acute lymphocytic leukemia 1 | NM_003189.1 | 1873.2, P | 1763.8, P | 0.03, NC | 1.1 |
Ecotropic viral integration site 1 | S82592.1 | —, A | —, A | —, NC | NA |
Core-binding factor, runt domain, alpha subunit 2; translocated to 3 | NM_005187.2 | 234.7, P | 377.1, P | 0.57, I | 1.6 |
Core-binding factor, runt domain, alpha subunit 2; translocated to 2 | NM_005093.1 | 69.1, P | 80.3, P | 0.33, NC | NA |
Chemokines | |||||
GRO1 oncogene (melanoma growth stimulating activity, alpha) | NM_001511.1 | 20.65, P | 157.8, P | 2.33, I | 3.2 |
Stromal cell-derived factor 1 | U19495.1 | 30.8, P | 62.9, P | 0.5, I | 2.6 |
Interleukin 8 | NM_000584.1 | 435.8, P | 1601.3, P | 1.87, I | 3.9 |
Proplatelet basic protein | R64130 | 4476.1, P | 4161.7, P | 0.06, NC | 0.7 |
Small inducible cytokine A5 (Rantes) | M21121 | 302.1, P | 524.3, P | 0.44, NC | NA |
Platelet factor 4 | NM_002619.1 | 6642.2, P | 7639.8, P | 0.12, NC | 0.7 |
Signal transducers | |||||
Signal transducer and activator of transcription | M97935 | 148.8, P | 132, P | 0.05, NC | NA |
Signal transducer and activator of transcription 3 | BC000627.1 | 503.3, P | 375.2, P | -0.46, NC | NA |
Signal transducer and activator of transcription 5A | NM_003152.1 | 229.9, P | 248.5, P | 0.11, NC | NA |
Mitogen-activated protein kinase 14 | NM_001315.1 | 681, P | 535.2, P | -0.57, D | 0.9 |
Janus kinase 2 (a protein tyrosine kinase) | NM_004972.2 | 45.5, P | 34.6, P | -0.08, NC | NA |
Phosphoinositide-3-kinase, class 2, beta polypeptide | NM_002646.1 | —, A | —, A | —, NC | NA |
P indicates present; NC, not changed; NA, not applicable; A, absent; I, increased; D, decreased; and —, absent gene showing aspecific signal.